Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Imatinib. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104072477B details a high-purity imatinib refining method controlling genotoxic impurities. Offers supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN112321535B reveals a novel ketone-based route for Imaric Acid, offering high purity and cost reduction for Imatinib manufacturing supply chains.